Frequently Asked Questions

  • How do I contact Biodesix?

    Click here

  • Is GeneStrat covered by insurance?

    Medicare covers GeneStrat mutation testing for lung and certain other cancers; coverage may also be available through other payers.

    For patients with Medicare or Medicaid, if you meet the criteria for coverage, there is no out-of pocket expense.
    For patients with Medicare Advantage or private insurance, you may have a copay, coinsurance, or deductible. If you need financial assistance, our Biodesix Assist Financial Support Program is available to potentially reduce or eliminate any remaining financial responsibility.

    For patients without insurance, the Biodesix Assist Financial Support Program is available for those who qualify.

    For more information about reimbursement or the Biodesix Assist Financial Support Program, please call a Biodesix Patient Advocate at 1.866.432.5930

  • How do I order a test kit?

    You can order by phone at 1-866-432-5930, or via this form. Test kits are only available to licensed physicians; if you are a patient, please speak with your physician about Biodesix testing.

  • Does Biodesix offer any financial assistance with the GeneStrat test?

    Biodesix is committed to making GeneStrat and VeriStrat available to all patients. Our experienced patient advocates will seek coverage for your test, and our Biodesix Assist Financial Support Program is available to those who qualify to reduce or eliminate potential patient financial responsibility. Patients may apply to pre-qualify for financial assistance at any time including applying before the test is performed. Patients may call and pre-qualify over the phone by contacting our Patient Advocates at 1.866.432.5930.

  • What are genetic mutations and why are they important to the treatment of my cancer?

    Genetic mutations are changes that occur within the DNA of a cancer cell. Some targeted therapies are known to be more effective for patients with specific mutations. Your individual genetic test results can help your physician guide your treatment plan.

  • For patients and caregivers


    What is GeneStrat?

    GeneStrat is a blood test for patients who have been diagnosed with advanced lung cancer. The test identifies certain genetic mutations in your tumor that could determine the course of your treatment. Based on your GeneStrat results, your physician may also order VeriStrat for additional information about your disease.

    GeneStrat test results provide physicians with information that can help make more informed treatment decisions.

    For patients with advanced lung cancer:

    • Test prior to making initial treatment decisions
    • Your doctor may also test for the T790M resistance mutation to identify disease progression or to potentially change your therapy

    Test results should be used in combination with the patient’s clinical history, other diagnostic tests, and clinicopathological factors, evaluated by a qualified physician.

  • For healthcare professionals

    Can you accelerate starting your patients on the right therapy?

    GeneStrat is a targeted liquid biopsy mutation test for patients with advanced lung cancer:

    When should the GeneStrat test be run? When you need rapid, actionable mutation results for therapy decisions and monitoring.

    • Prior to making 1st-line treatment decisions
    • T790M for identifying progression on EGFR-TKI therapy

    When should the GeneStrat test be run? When you need rapid, actionable mutation results for therapy decisions and monitoring.

    • Prior to making 1st-line treatment decisions
    • T790M for identifying progression on EGFR-TKI therapy

    Reflex to VeriStrat when patient is EGFR wild-type

    Treatment Pathway

    Test results should be used in combination with the patient’s clinical history, other diagnostic tests, and clinicopathological factors, evaluated by a qualified physician.